Risk Management

Risk Management for Medical Device

Contact Us

Are You Looking For Medical Devices Certifications?

Click Now!

Connect With Us

    The concept of Risk Management for Medical Device and In-Vitro Diagnostic Device is complex because of the diversity of collaborators including medical practitioners, the organizations providing health care, governments, industry, patients and members of the public.

    It is to be understood by the collaborators that use of such devices involve a great degree of risk even if the risk is reduced to an acceptable level.

    ISO 14971 assist the manufacturers of the medical device to identify the hazards associated with the medical device.

    Risk Management

    Risk Management for Medical Device & In-vitro Diagnostic Device:

    Risk Management for Medical Device is an integral part of the Medical Device Quality Management System (MD-QMS).

    Risk Management for Medical Device includes establishment, implementation, documentation and maintenance of ongoing processes of Medical Device:

    • Risk Analysis: Identifying hazards and hazardous situations associated with a medical device;
    • Risk Evaluation: Estimating and evaluating the associated risks;
    • Risk Control: Controlling these risks, and
    • Production and Post Production: Monitoring the effectiveness of the risk control measures.

    Medical Device & IVD Device Risk Management File:

    For each type of medical device, the Medical device Risk Management file is maintained.

    The elements of the Risk Management file include:

    • Reference of Design History File
    • Risk Policy
    • Risk Management Plan
    • Risk Management Report
    • Reference of PMS process,

    Risk Management for Medical Device include Stages:

    • Risk Analysis
      • the Risk Analysis process
      • Intended use and reasonably foreseeable misuse
      • Identification of characteristics related to the safety
      • Identification of hazard and hazardous situation
      • Risk Estimation
    • Risk Evaluation
    • Risk Control
      • Risk Control option Analysis
      • Implementation of Risk Control Measure
      • Residual Risk Evaluation
      • Benefit-Risk Analysis
      • Risk arising from risk control measures
      • Completeness of Risk Control
    • Evaluation of Overall residual risk
    • Risk Management Review
    • Production and Post- Production activities

    For more details refer our blog:

    Residual Risk

    If during risk control option analysis, the manufacturer determines that risk reduction is not practicable, the manufacturer shall conduct a benefit-risk analysis of the residual risk. After the risk control measures are implemented, the manufacturer shall evaluate the residual risk using the criteria for risk acceptability defined in the risk management plan. If a residual risk is not judged acceptable using the criteria established in the risk management plan and further risk control is not practicable, the manufacturer may gather and review data and literature to determine if the benefits of the intended use outweigh this residual risk.

    If the overall residual risk is judged acceptable, the manufacturer shall inform users of significant residual risks and shall include the necessary information in the accompanying documentation in order to disclose those residual risks.

    Risk and Technical Documentation:

    The residual risks are communicated to the intended user in the information supplied to manufacturer- Instructions for Use and Label.

    Both risk management and clinical evaluation are interdependent. As a part of clinical evaluation, all the clinical risks are identified and are integrated in the risk management file.

    Risk Management is also linked with PMS activities. The manufacturer will collect information from various sources about the similar medical devices and other products on market and shall consider the information as an input to risk management. Also, the conclusions of the risk and benefit-risk analysis will be fed into PMS report and Periodic safety Update Report.

    Ways Consultants (WE) can serve Clients (YOU)

    • Uncovering the loopholes in the existing Documents
    • Analyzing and Identification of New Hazard’s that were previously unrecognized.
    • Drafting the protocol for Risk Management as per the current Harmonized Standard
    • Providing the clients with Medical Device Risk Management File
    • Conduct Risk-Benefit Analysis and demonstrate that medical device benefit outweighs the residual risk involved
    • Updating the risk management files with respect to post-market data updates.
    • We assist you to acquire your certifications within the given Time Frame


    Software failure; exceptional misuse situations, such as sabotage or tampering with a medical device;

    Novel hazards that are poorly understood, e.g. imprecise knowledge of the infectivity of the causative How to the agent of Bovine Spongiform Encephalopathy (BSE) prevents quantification of the risk of transmission;

    Certain toxicological hazards, such as genotoxic carcinogens and sensitizing agents, where it might not be possible to determine a threshold of exposure below which toxic effects do not occur.

    FMEA means Failure mode and effects analysis.

    • Identify various functions of the medical device.
    • Identify failure for each function.
    • For each failure identify the consequences (Potential effects)
    • Determine the severity of each effect. Mention the highest severity rating in the table for that particular failure.
    • Determine the root cause for each failure.
    • For each cause determine the probability of occurrence. Mention the occurrence of rating in the FMEA table.
    • Calculate risk priority number i.e. RPN= Severity X occurrence.
    • This will provide the potential failure in the order that is to be addressed.
    • Determine the actions to lower the severity or occurrence

    The various methods of risk analysis are:

    • Fault Tree Analysis (FTA), Mind map Analysis, Preliminary Hazard Analysis (PHA), Failure Mode and Effects Analysis (FMEA), Parameter diagram (P-Diagram).
    • OR
    • Semi-quantitative, Quantitative, Qualitative.

    Our Blogs


    Blog Image

    June 13th, 2024

    Understanding the Premarket Notification 510(k) Process: Path to FDA Approval

    Read More
    Blog Image

    June 6th, 2024

    Key Components Of Clean Room Design

    Read More
    Blog Image

    May 16th, 2024

    Navigating Regulatory Challenges For Drug-Device Combination Products in EU

    Read More

    Connect With Us